Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0OE0D
|
|||
| Drug Name |
PMID27215781-Compound-33
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
C4T S.C. A.R.L
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C24H22FNO5S
|
|||
| Canonical SMILES |
CC1=CC=C(C=C1)S(=O)(=O)OC2=CC3=C(C=C2)C(=O)N(C(O3)(C)C)CC4=CC=C(C=C4)F
|
|||
| InChI |
1S/C24H22FNO5S/c1-16-4-11-20(12-5-16)32(28,29)31-19-10-13-21-22(14-19)30-24(2,3)26(23(21)27)15-17-6-8-18(25)9-7-17/h4-14H,15H2,1-3H3
|
|||
| InChIKey |
RDCDFXNTJYTRNH-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Cannabinoid receptor 2 (CB2) | Target Info | . | [1] |
| Target's Patent Info | Cannabinoid receptor 2 (CB2) | Target's Patent Info | [1] | |
| KEGG Pathway | Neuroactive ligand-receptor interaction | |||
| Reactome | Class A/1 (Rhodopsin-like receptors) | |||
| G alpha (i) signalling events | ||||
| WikiPathways | GPCRs, Class A Rhodopsin-like | |||
| Small Ligand GPCRs | ||||
| GPCR ligand binding | ||||
| GPCR downstream signaling | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Cannabinoid receptor 2 (CB2) agonists and antagonists: a patent update.Expert Opin Ther Pat. 2016 Jul;26(7):843-56. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.